FDA updates modular review program guidance; adds humanitarian device exemptions
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesCBERCDRHDiagnostics/IVDsGuidanceMedical DevicesRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)